These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7587121)

  • 21. Human gene MAGE-1, which codes for a tumor-rejection antigen, is expressed by some breast tumors.
    Brasseur F; Marchand M; Vanwijck R; Hérin M; Lethé B; Chomez P; Boon T
    Int J Cancer; 1992 Nov; 52(5):839-41. PubMed ID: 1428237
    [No Abstract]   [Full Text] [Related]  

  • 22. New antigens presented on tumor cells can cause immune rejection without influencing the frequency of tumor-specific cytolytic T cells.
    von Hoegen P; Altevogt P; Schirrmacher V
    Cell Immunol; 1987 Oct; 109(2):338-48. PubMed ID: 3117377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recognition of tumor-associated antigens by T lymphocytes: from basic concepts to new approaches.
    Cerottini JC; von Fliedner V; Boon T
    Ann Oncol; 1992 Jan; 3(1):11-6. PubMed ID: 1606063
    [No Abstract]   [Full Text] [Related]  

  • 24. Expansion of cancer germline antigen-specific cytotoxic T lymphocytes for immunotherapy.
    Krishnadas DK; Wang Y; Sundaram K; Bai F; Lucas KG
    Tumour Biol; 2017 Jul; 39(7):1010428317701309. PubMed ID: 28677424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of MAGE-1 gene by esophageal carcinomas.
    Toh Y; Yamana H; Shichijo S; Fujita H; Tou U; Sakaguchi M; Kakegawa T; Itoh K
    Jpn J Cancer Res; 1995 Aug; 86(8):714-7. PubMed ID: 7559092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of a second major tumor-specific antigen recognized by CTLs on mouse mastocytoma P815.
    Bilsborough J; Van Pel A; Uyttenhove C; Boon T; Van den Eynde BJ
    J Immunol; 1999 Mar; 162(6):3534-40. PubMed ID: 10092811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mouse tumor rejection antigens P815A and P815B: two epitopes carried by a single peptide.
    Lethé B; van den Eynde B; van Pel A; Corradin G; Boon T
    Eur J Immunol; 1992 Sep; 22(9):2283-8. PubMed ID: 1381312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of a gene coding for a protein possessing shared tumor epitopes capable of inducing HLA-A24-restricted cytotoxic T lymphocytes in cancer patients.
    Yang D; Nakao M; Shichijo S; Sasatomi T; Takasu H; Matsumoto H; Mori K; Hayashi A; Yamana H; Shirouzu K; Itoh K
    Cancer Res; 1999 Aug; 59(16):4056-63. PubMed ID: 10463607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of the MAGE-1, -2, -3, -4, and -6 genes in non-squamous cell carcinoma lesions of the head and neck.
    Lee KD; Eura M; Ogi K; Nakano K; Chikamatsu K; Masuyama K; Ishikawa T
    Acta Otolaryngol; 1996 Jul; 116(4):633-9. PubMed ID: 8831854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. IV. Analysis of variant-specific antigens by selection of antigen-loss variants with cytolytic T cell clones.
    Maryanski JL; Boon T
    Eur J Immunol; 1982 May; 12(5):406-12. PubMed ID: 6178608
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genes coding for melanoma antigens recognised by cytolytic T lymphocytes.
    De Smet C; Lurquin C; De Plaen E; Brasseur F; Zarour H; De Backer O; Coulie PG; Boon T
    Eye (Lond); 1997; 11 ( Pt 2)():243-8. PubMed ID: 9349420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Localization of two cytotoxic T lymphocyte epitopes and three anchoring residues on a single nonameric peptide that binds to H-2Ld and is recognized by cytotoxic T lymphocytes against mouse tumor P815.
    Van den Eynde B; Mazarguil H; Lethé B; Laval F; Gairin JE
    Eur J Immunol; 1994 Nov; 24(11):2740-5. PubMed ID: 7525302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes.
    Gaugler B; Van den Eynde B; van der Bruggen P; Romero P; Gaforio JJ; De Plaen E; Lethé B; Brasseur F; Boon T
    J Exp Med; 1994 Mar; 179(3):921-30. PubMed ID: 8113684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Human tumor-rejection antigens and peptides from genes to clinical research].
    Itoh K; Yamana H; Shichijo S; Yamada A
    Nihon Geka Gakkai Zasshi; 2000 Sep; 101(9):612-7. PubMed ID: 11022676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of genes coding for tumor antigens recognized by cytolytic T lymphocytes.
    De Plaen E; Lurquin C; Lethé B; van der Bruggen P; Brichard V; Renauld JC; Coulie P; Van Pel A; Boon T
    Methods; 1997 Jun; 12(2):125-42. PubMed ID: 9184377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Rejection antigens of tumors and specific immunotherapy of cancer].
    Boon T; Lucas S
    Bull Mem Acad R Med Belg; 1996; 151(12):469-79. PubMed ID: 9491625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Immunological analysis of melanoma-specific antigen].
    Wakabayashi S; Okamoto S
    Nihon Hifuka Gakkai Zasshi; 1985 Oct; 95(11):1145-51. PubMed ID: 3879298
    [No Abstract]   [Full Text] [Related]  

  • 38. The immunogenic properties of melanoma-associated antigens recognized by cytotoxic T lymphocytes.
    Kirkin AF; Dzhandzhugazyan K; Zeuthen J
    Exp Clin Immunogenet; 1998; 15(1):19-32. PubMed ID: 9619397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of cancer immunotherapies based on identification of the genes encoding cancer regression antigens.
    Rosenberg SA
    J Natl Cancer Inst; 1996 Nov; 88(22):1635-44. PubMed ID: 8931607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Tumor specific antigen and cytotoxic T lymphocytes].
    Uenaka A; Nakayama E
    Nihon Rinsho; 2005 Apr; 63 Suppl 4():568-73. PubMed ID: 15861712
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.